Doxercalciferol
- TRADE NAME: Hectorol (Genzyme)
- INDICATIONS: Secondary hyperparathyroidism in patients with chronic kidney disease on dialysis
- CLASS: Vitamin D receptor agonist
- HALF-LIFE: 32–37 hours
CLINICALLY IMPORTANT, POTENTIALLY HAZARDOUS INTERACTIONS WITH:
Aminoglutethimide, Cholestyramine, Erythromycin, Ketoconazole, Magnesium-containing antacids, Mineral oil, Phenobarbital
PREGNANCY CATEGORY: B
Contra-indicated in patients with a tendency towards hypercalcemia or current evidence of vitamin D toxicity.
Please login to see the rest of this drug profile
SKIN.
CARDIOVASCULAR.
CENTRAL NERVOUS SYSTEM.
ENDOCRINE/METABOLIC.
GASTROINTESTINAL/HEPATIC.
NEUROMUSCULAR/SKELETAL.
RESPIRATORY.
Page last updated 07/31/2023
Symbol key
Incidence
- <1%
- 1-5%
- 5-10%
- 10-15%
- 15-20%
- 20-30%
- >30%
Warnings in other populations
- Breast feeding
- Geriatric
- Pediatric